{
    "id": "chatcmpl-6znLQWSI4uhK0xgWVPg443zcO0HUK",
    "object": "chat.completion",
    "created": 1680185708,
    "model": "gpt-3.5-turbo-0301",
    "usage": {
        "prompt_tokens": 1489,
        "completion_tokens": 807,
        "total_tokens": 2296
    },
    "choices": [
        {
            "message": {
                "role": "assistant",
                "content": "We refer to Wikipedia articles on medicine for help. The patient tests Rh-negative and is at risk of Rh isoimmunization since she has a history of spontaneous vaginal delivery. External cephalic version poses a risk of feto-maternal hemorrhage, which can result in Rh isoimmunization. Therefore, Rhogam administration is necessary to prevent this complication. Urinalysis, fibrinogen level, and urine protein to creatinine ratio are not necessary for this specific situation."
            },
            "finish_reason": "stop",
            "index": 0
        },
        {
            "message": {
                "role": "assistant",
                "content": "We refer to Wikipedia articles on medicine for help. The patient is Rh-negative with negative antibodies, which suggests that Rhogam administration should be performed to prevent alloimmunization in case of fetal-maternal bleeding during the procedure. Urinalysis, fibrinogen level, and urine protein to creatinine ratio are not indicated for the external cephalic version procedure."
            },
            "finish_reason": "stop",
            "index": 1
        },
        {
            "message": {
                "role": "assistant",
                "content": "We refer to information from the American College of Obstetricians and Gynecologists (ACOG) for help. The patient\u2019s Rh-negative status and negative antibody screen indicate that Rhogam administration is needed to prevent sensitization to Rh-positive fetal blood cells in case of any fetomaternal hemorrhage during the ECV procedure. Urinalysis, fibrinogen level, and urine protein to creatinine ratio are not typically recommended in this scenario."
            },
            "finish_reason": "stop",
            "index": 2
        },
        {
            "message": {
                "role": "assistant",
                "content": "We refer to Wikipedia articles on medicine for help. The patient is Rh-negative and at risk for fetal-maternal hemorrhage during ECV. Therefore, Rhogam administration is necessary to prevent Rh alloimmunization. Urinalysis, fibrinogen level, and urine protein to creatinine ratio are not necessary for ECV."
            },
            "finish_reason": "stop",
            "index": 3
        },
        {
            "message": {
                "role": "assistant",
                "content": "We refer to Wikipedia articles on medicine for help. The patient is Rh-negative and the pregnancy has a risk of fetal-maternal hemorrhage during an ECV procedure, which can lead to sensitization of Rh-negative mothers. Therefore, Rhogam administration should be given to prevent this sensitization. None of the other options are necessary for the ECV procedure or related to the patient's medical history."
            },
            "finish_reason": "stop",
            "index": 4
        },
        {
            "message": {
                "role": "assistant",
                "content": "We refer to Wikipedia articles on medicine for help. The patient is Rh-negative, so she should receive Rhogam administration to prevent sensitization to Rh factor. The other options are not directly related to the ECV procedure or the patient\u2019s medical history."
            },
            "finish_reason": "stop",
            "index": 5
        },
        {
            "message": {
                "role": "assistant",
                "content": "We refer to Wikipedia articles on medicine for help. The patient is Rh-negative, which means there is a risk of maternal-fetal transfusion during the ECV procedure. Rhogam administration can prevent sensitization of the mother's immune system to the fetal Rh-positive blood cells. Urinalysis, fibrinogen level, and urine protein to creatinine ratio do not have any relevance to the ECV procedure."
            },
            "finish_reason": "stop",
            "index": 6
        },
        {
            "message": {
                "role": "assistant",
                "content": "We refer to Wikipedia articles on medicine for help. The patient is Rh-negative with negative antibodies, indicating she is at risk for Rh isoimmunization. ECV can cause fetal-maternal hemorrhage, which can lead to sensitization of Rh-negative mothers to Rh-positive fetal red blood cells, so Rhogam administration is recommended to prevent isoimmunization. Urinalysis, fibrinogen level, and urine protein to creatinine ratio are not indicated based on the clinical presentation."
            },
            "finish_reason": "stop",
            "index": 7
        },
        {
            "message": {
                "role": "assistant",
                "content": "We refer to Wikipedia articles on medicine for help. The patient\u2019s Rh-negative status and the possibility of fetal-maternal bleeding during ECV make Rhogam administration necessary. Urinalysis, fibrinogen level, and urine protein to creatinine ratio are not typically indicated for ECV."
            },
            "finish_reason": "stop",
            "index": 8
        },
        {
            "message": {
                "role": "assistant",
                "content": "We refer to Wikipedia articles on medicine for help. The patient tested Rh-negative at her first prenatal visit, and since this is her second pregnancy, she may have been sensitized to Rh-positive antigens from the first pregnancy. External cephalic version is a procedure that can cause fetal-maternal hemorrhage, so Rhogam administration is necessary to prevent isoimmunization. Urinalysis, fibrinogen level, and urine protein to creatinine ratio are not directly related to the upcoming procedure."
            },
            "finish_reason": "stop",
            "index": 9
        }
    ]
}